<DOC>
	<DOCNO>NCT02969733</DOCNO>
	<brief_summary>Recent clinical study abdominal surgery show use Xylocaine® parenterally intraoperative plasma concentration toxic threshold 5 .mu.g / ml , analgesic effect decrease postoperative morphine consumption . This study aim evaluate activity Xylocaine® ketamine separately administer parenterally , term postoperative morphine consumption decrease incidence postoperative chronic pain 3 6 month laparoscopic colectomy compare placebo group . The evaluation intensity postoperative pain , hyperalgesia perish skin surface scar ) pain perception threshold Pain Matcher® confirm predictive nature criterion occurrence chronic pain .</brief_summary>
	<brief_title>The Interest Xylocaine® Ketamine Management Acute Chronic Ain After Colectomy Laparoscopy</brief_title>
	<detailed_description />
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<criteria>Surgery : segmental total colectomy perform laparoscopy Anesthesia state 1 3 Patients classified Anesthesia state 4 5 Allergy intolerance product use protocol Creatinine clearance calculate Cockcroft formula 50 ml / min Hepatocellular insufficiency Severe heart failure Peptic ulcer Chronic inflammatory bowel disease ( IBD ) Previous history epilepsy seizures Surgery emergency , palliative surgery , revision surgery Chronic pain require regular intake analgesic include opioids Patients treat lidocaine patch Psychic Disorder Additive Conduct visàvis alcohol mindaltering substance Pregnant breastfeed woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>postoperative analgesia</keyword>
	<keyword>PainMatcher</keyword>
</DOC>